Home > > > Report Detail

Global Central Nervous System (CNS) Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 19-Nov-2021
No. of pages: 92

The Central Nervous System (CNS) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Central Nervous System (CNS) Drug size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Central Nervous System (CNS) Drug market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Central Nervous System (CNS) Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Prescription Drugs

- OTC

Market segment by Application, can be divided into

- MS Therapeutics

- Antipsychotic Drugs

- Depression Drugs

- Epilepsy Drugs

- Others

Market segment by players, this report covers

- Johnson & Johnson

- Pfizer Inc

- Novartis AG

- GSK

- Eli Lilly

- Teva

- Otsuka Pharmaceutical Co., Ltd

- Biogen Inc

- Boehringer Ingelheim

- Roche

- UCB

- Tekeda

- Shanghai Fosun

- Jiangsu Nhwa Pharmaceutical Co., Ltd.

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Central Nervous System (CNS) Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Central Nervous System (CNS) Drug, with revenue, gross margin and global market share of Central Nervous System (CNS) Drug from 2019 to 2021.

Chapter 3, the Central Nervous System (CNS) Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Central Nervous System (CNS) Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Central Nervous System (CNS) Drug research findings and conclusion, appendix and data source.

Global Central Nervous System (CNS) Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Central Nervous System (CNS) Drug
1.2 Classification of Central Nervous System (CNS) Drug by Type
1.2.1 Overview: Global Central Nervous System (CNS) Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Central Nervous System (CNS) Drug Revenue Market Share by Type in 2020
1.2.3 Prescription Drugs
1.2.4 OTC
1.3 Global Central Nervous System (CNS) Drug Market by Application
1.3.1 Overview: Global Central Nervous System (CNS) Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 MS Therapeutics
1.3.3 Antipsychotic Drugs
1.3.4 Depression Drugs
1.3.5 Epilepsy Drugs
1.3.6 Others
1.4 Global Central Nervous System (CNS) Drug Market Size & Forecast
1.5 Global Central Nervous System (CNS) Drug Market Size and Forecast by Region
1.5.1 Global Central Nervous System (CNS) Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Central Nervous System (CNS) Drug Market Size by Region, (2016-2021)
1.5.3 North America Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
1.5.6 South America Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Central Nervous System (CNS) Drug Market Drivers
1.6.2 Central Nervous System (CNS) Drug Market Restraints
1.6.3 Central Nervous System (CNS) Drug Trends Analysis
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Product and Solutions
2.1.4 Johnson & Johnson Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business
2.2.3 Pfizer Inc Central Nervous System (CNS) Drug Product and Solutions
2.2.4 Pfizer Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Inc Recent Developments and Future Plans
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Central Nervous System (CNS) Drug Product and Solutions
2.3.4 Novartis AG Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis AG Recent Developments and Future Plans
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Central Nervous System (CNS) Drug Product and Solutions
2.4.4 GSK Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GSK Recent Developments and Future Plans
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Central Nervous System (CNS) Drug Product and Solutions
2.5.4 Eli Lilly Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Eli Lilly Recent Developments and Future Plans
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Central Nervous System (CNS) Drug Product and Solutions
2.6.4 Teva Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Teva Recent Developments and Future Plans
2.7 Otsuka Pharmaceutical Co., Ltd
2.7.1 Otsuka Pharmaceutical Co., Ltd Details
2.7.2 Otsuka Pharmaceutical Co., Ltd Major Business
2.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product and Solutions
2.7.4 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Otsuka Pharmaceutical Co., Ltd Recent Developments and Future Plans
2.8 Biogen Inc
2.8.1 Biogen Inc Details
2.8.2 Biogen Inc Major Business
2.8.3 Biogen Inc Central Nervous System (CNS) Drug Product and Solutions
2.8.4 Biogen Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Biogen Inc Recent Developments and Future Plans
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Product and Solutions
2.9.4 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Boehringer Ingelheim Recent Developments and Future Plans
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche Central Nervous System (CNS) Drug Product and Solutions
2.10.4 Roche Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Roche Recent Developments and Future Plans
2.11 UCB
2.11.1 UCB Details
2.11.2 UCB Major Business
2.11.3 UCB Central Nervous System (CNS) Drug Product and Solutions
2.11.4 UCB Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 UCB Recent Developments and Future Plans
2.12 Tekeda
2.12.1 Tekeda Details
2.12.2 Tekeda Major Business
2.12.3 Tekeda Central Nervous System (CNS) Drug Product and Solutions
2.12.4 Tekeda Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Tekeda Recent Developments and Future Plans
2.13 Shanghai Fosun
2.13.1 Shanghai Fosun Details
2.13.2 Shanghai Fosun Major Business
2.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Product and Solutions
2.13.4 Shanghai Fosun Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Shanghai Fosun Recent Developments and Future Plans
2.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
2.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Details
2.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Major Business
2.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product and Solutions
2.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Central Nervous System (CNS) Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Central Nervous System (CNS) Drug Players Market Share
3.2.2 Top 10 Central Nervous System (CNS) Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Central Nervous System (CNS) Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Central Nervous System (CNS) Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Central Nervous System (CNS) Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2016-2021)
5.2 Central Nervous System (CNS) Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
6.2 North America Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
6.3 North America Central Nervous System (CNS) Drug Market Size by Country
6.3.1 North America Central Nervous System (CNS) Drug Revenue by Country (2016-2026)
6.3.2 United States Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
7.2 Europe Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
7.3 Europe Central Nervous System (CNS) Drug Market Size by Country
7.3.1 Europe Central Nervous System (CNS) Drug Revenue by Country (2016-2026)
7.3.2 Germany Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
7.3.3 France Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region
8.3.1 Asia-Pacific Central Nervous System (CNS) Drug Revenue by Region (2016-2026)
8.3.2 China Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
8.3.5 India Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
9.2 South America Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
9.3 South America Central Nervous System (CNS) Drug Market Size by Country
9.3.1 South America Central Nervous System (CNS) Drug Revenue by Country (2016-2026)
9.3.2 Brazil Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country
10.3.1 Middle East & Africa Central Nervous System (CNS) Drug Revenue by Country (2016-2026)
10.3.2 Turkey Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Central Nervous System (CNS) Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Central Nervous System (CNS) Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Central Nervous System (CNS) Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Central Nervous System (CNS) Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Central Nervous System (CNS) Drug Revenue Market Share by Region (2021-2026)
Table 6. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 7. Johnson & Johnson Major Business
Table 8. Johnson & Johnson Central Nervous System (CNS) Drug Product and Solutions
Table 9. Johnson & Johnson Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Inc Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Inc Major Business
Table 12. Pfizer Inc Central Nervous System (CNS) Drug Product and Solutions
Table 13. Pfizer Inc Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 15. Novartis AG Major Business
Table 16. Novartis AG Central Nervous System (CNS) Drug Product and Solutions
Table 17. Novartis AG Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GSK Corporate Information, Head Office, and Major Competitors
Table 19. GSK Major Business
Table 20. GSK Central Nervous System (CNS) Drug Product and Solutions
Table 21. GSK Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 23. Eli Lilly Major Business
Table 24. Eli Lilly Central Nervous System (CNS) Drug Product and Solutions
Table 25. Eli Lilly Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Teva Corporate Information, Head Office, and Major Competitors
Table 27. Teva Major Business
Table 28. Teva Central Nervous System (CNS) Drug Product and Solutions
Table 29. Teva Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Otsuka Pharmaceutical Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 31. Otsuka Pharmaceutical Co., Ltd Major Business
Table 32. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product and Solutions
Table 33. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Biogen Inc Corporate Information, Head Office, and Major Competitors
Table 35. Biogen Inc Major Business
Table 36. Biogen Inc Central Nervous System (CNS) Drug Product and Solutions
Table 37. Biogen Inc Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 39. Boehringer Ingelheim Major Business
Table 40. Boehringer Ingelheim Central Nervous System (CNS) Drug Product and Solutions
Table 41. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Roche Corporate Information, Head Office, and Major Competitors
Table 43. Roche Major Business
Table 44. Roche Central Nervous System (CNS) Drug Product and Solutions
Table 45. Roche Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. UCB Corporate Information, Head Office, and Major Competitors
Table 47. UCB Major Business
Table 48. UCB Central Nervous System (CNS) Drug Product and Solutions
Table 49. UCB Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Tekeda Corporate Information, Head Office, and Major Competitors
Table 51. Tekeda Major Business
Table 52. Tekeda Central Nervous System (CNS) Drug Product and Solutions
Table 53. Tekeda Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Shanghai Fosun Corporate Information, Head Office, and Major Competitors
Table 55. Shanghai Fosun Major Business
Table 56. Shanghai Fosun Central Nervous System (CNS) Drug Product and Solutions
Table 57. Shanghai Fosun Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Jiangsu Nhwa Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 59. Jiangsu Nhwa Pharmaceutical Co., Ltd. Major Business
Table 60. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product and Solutions
Table 61. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Central Nervous System (CNS) Drug Revenue (USD Million) by Players (2019-2021)
Table 63. Global Central Nervous System (CNS) Drug Revenue Share by Players (2019-2021)
Table 64. Breakdown of Central Nervous System (CNS) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Central Nervous System (CNS) Drug Players Head Office, Products and Services Provided
Table 66. Central Nervous System (CNS) Drug Mergers & Acquisitions in the Past Five Years
Table 67. Central Nervous System (CNS) Drug New Entrants and Expansion Plans
Table 68. Global Central Nervous System (CNS) Drug Revenue (USD Million) by Type (2016-2021)
Table 69. Global Central Nervous System (CNS) Drug Revenue Share by Type (2016-2021)
Table 70. Global Central Nervous System (CNS) Drug Revenue Forecast by Type (2021-2026)
Table 71. Global Central Nervous System (CNS) Drug Revenue by Application (2016-2021)
Table 72. Global Central Nervous System (CNS) Drug Revenue Forecast by Application (2021-2026)
Table 73. North America Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Central Nervous System (CNS) Drug Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Central Nervous System (CNS) Drug Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Central Nervous System (CNS) Drug Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Central Nervous System (CNS) Drug Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Central Nervous System (CNS) Drug Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Central Nervous System (CNS) Drug Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Central Nervous System (CNS) Drug Picture
Figure 2. Global Central Nervous System (CNS) Drug Revenue Market Share by Type in 2020
Figure 3. Prescription Drugs
Figure 4. OTC
Figure 5. Central Nervous System (CNS) Drug Revenue Market Share by Application in 2020
Figure 6. MS Therapeutics Picture
Figure 7. Antipsychotic Drugs Picture
Figure 8. Depression Drugs Picture
Figure 9. Epilepsy Drugs Picture
Figure 10. Others Picture
Figure 11. Global Central Nervous System (CNS) Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Central Nervous System (CNS) Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Central Nervous System (CNS) Drug Revenue Market Share by Region (2016-2026)
Figure 14. Global Central Nervous System (CNS) Drug Revenue Market Share by Region in 2020
Figure 15. North America Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Central Nervous System (CNS) Drug Market Drivers
Figure 21. Central Nervous System (CNS) Drug Market Restraints
Figure 22. Central Nervous System (CNS) Drug Market Trends
Figure 23. Johnson & Johnson Recent Developments and Future Plans
Figure 24. Pfizer Inc Recent Developments and Future Plans
Figure 25. Novartis AG Recent Developments and Future Plans
Figure 26. GSK Recent Developments and Future Plans
Figure 27. Eli Lilly Recent Developments and Future Plans
Figure 28. Teva Recent Developments and Future Plans
Figure 29. Otsuka Pharmaceutical Co., Ltd Recent Developments and Future Plans
Figure 30. Biogen Inc Recent Developments and Future Plans
Figure 31. Boehringer Ingelheim Recent Developments and Future Plans
Figure 32. Roche Recent Developments and Future Plans
Figure 33. UCB Recent Developments and Future Plans
Figure 34. Tekeda Recent Developments and Future Plans
Figure 35. Shanghai Fosun Recent Developments and Future Plans
Figure 36. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Figure 37. Global Central Nervous System (CNS) Drug Revenue Share by Players in 2020
Figure 38. Central Nervous System (CNS) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Central Nervous System (CNS) Drug Revenue Market Share in 2020
Figure 40. Global Top 10 Players Central Nervous System (CNS) Drug Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Central Nervous System (CNS) Drug Revenue Share by Type in 2020
Figure 43. Global Central Nervous System (CNS) Drug Market Share Forecast by Type (2021-2026)
Figure 44. Global Central Nervous System (CNS) Drug Revenue Share by Application in 2020
Figure 45. Global Central Nervous System (CNS) Drug Market Share Forecast by Application (2021-2026)
Figure 46. North America Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
Figure 47. North America Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
Figure 48. North America Central Nervous System (CNS) Drug Revenue Market Share by Country (2016-2026)
Figure 49. United States Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
Figure 53. Europe Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
Figure 54. Europe Central Nervous System (CNS) Drug Revenue Market Share by Country (2016-2026)
Figure 55. Germany Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Central Nervous System (CNS) Drug Revenue Market Share by Region (2016-2026)
Figure 63. China Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
Figure 70. South America Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
Figure 71. South America Central Nervous System (CNS) Drug Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Central Nervous System (CNS) Drug Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs